{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:42:32Z","timestamp":1780537352515,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR075241"],"award-info":[{"award-number":["R01AR075241"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R00DA035865"],"award-info":[{"award-number":["R00DA035865"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA284075"],"award-info":[{"award-number":["R01CA284075"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21AA028321"],"award-info":[{"award-number":["R21AA028321"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R00AA025393"],"award-info":[{"award-number":["R00AA025393"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R21AA030862"],"award-info":[{"award-number":["R21AA030862"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA031452"],"award-info":[{"award-number":["R01AA031452"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["P60AA006420"],"award-info":[{"award-number":["P60AA006420"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA012602"],"award-info":[{"award-number":["R01AA012602"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["U01AA025476"],"award-info":[{"award-number":["U01AA025476"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry Global Open Science"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bpsgos.2024.100368","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:59:17Z","timestamp":1722038357000},"page":"100368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Predictive Value of Plasma Bioactive Lipids on Craving in Human Volunteers With Alcohol Use Disorder"],"prefix":"10.1016","volume":"4","author":[{"given":"Cristina","family":"Miliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Natividad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Quello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Stoolmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Gregus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Buczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpsgos.2024.100368_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.bpsgos.2024.100368_bib2","series-title":"Facing Addiction in America: The Surgeon General\u2019s Report on Alcohol, Drugs, and Health","year":"2016"},{"key":"10.1016\/j.bpsgos.2024.100368_bib3","doi-asserted-by":"crossref","first-page":"07","DOI":"10.35946\/arcr.v41.1.07","article-title":"Alcohol use disorder: The role of medication in recovery","volume":"41","author":"Mason","year":"2021","journal-title":"Alcohol Res"},{"key":"10.1016\/j.bpsgos.2024.100368_bib4","series-title":"Alcohol: Neurobiology of Addiction","author":"Koob","year":"2021"},{"key":"10.1016\/j.bpsgos.2024.100368_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrn4004","article-title":"Endocannabinoid signalling in reward and addiction","volume":"16","author":"Parsons","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bpsgos.2024.100368_bib6","doi-asserted-by":"crossref","first-page":"09","DOI":"10.35946\/arcr.v42.1.09","article-title":"Alcohol-endocannabinoid interactions: Implications for addiction-related behavioral processes","volume":"42","author":"Serrano","year":"2022","journal-title":"Alcohol Res"},{"key":"10.1016\/j.bpsgos.2024.100368_bib7","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/adb.12408","article-title":"Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: Effect of length of abstinence","volume":"22","author":"Garcia-Marchena","year":"2017","journal-title":"Addict Biol"},{"key":"10.1016\/j.bpsgos.2024.100368_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00213-009-1518-3","article-title":"An endocannabinoid signal associated with desire for alcohol is suppressed in recently abstinent alcoholics","volume":"205","author":"Mangieri","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bpsgos.2024.100368_bib9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bpsgos.2024.100368_bib10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.neurobiolaging.2013.11.003","article-title":"Overexpression of 12\/15-lipoxygenase increases anxiety behavior in female mice","volume":"35","author":"Joshi","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bpsgos.2024.100368_bib11","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1097\/j.pain.0000000000001373","article-title":"Inhibition of spinal 15-LOX-1 attenuates TLR4-dependent, nonsteroidal anti-inflammatory drug-unresponsive hyperalgesia in male rats","volume":"159","author":"Gregus","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.bpsgos.2024.100368_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tips.2015.01.005","article-title":"The 12\/15-lipoxygenase as an emerging therapeutic target for Alzheimer\u2019s disease","volume":"36","author":"Joshi","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bpsgos.2024.100368_bib13","doi-asserted-by":"crossref","first-page":"8976","DOI":"10.1038\/s41598-017-02759-0","article-title":"Hepatic overproduction of 13-HODE due to ALOX15 upregulation contributes to alcohol-induced liver injury in mice","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpsgos.2024.100368_bib14","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1073\/pnas.1110460109","article-title":"Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors","volume":"109","author":"Gregus","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bpsgos.2024.100368_bib15","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1096\/fj.12-217414","article-title":"Systematic analysis of rat 12\/15-lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia","volume":"27","author":"Gregus","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.bpsgos.2024.100368_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.drugalcdep.2017.03.043","article-title":"Differences in biomarkers of crack-cocaine adolescent users before\/after abstinence","volume":"177","author":"Pianca","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.bpsgos.2024.100368_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1530-0277.1998.tb03637.x","article-title":"Increased circulating products of lipid peroxidation in patients with alcoholic liver disease","volume":"22","author":"Aleynik","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.bpsgos.2024.100368_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1369-1600.2008.00133.x","article-title":"Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: Effects of gabapentin","volume":"14","author":"Mason","year":"2009","journal-title":"Addict Biol"},{"key":"10.1016\/j.bpsgos.2024.100368_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nrd2828","article-title":"Development of pharmacotherapies for drug addiction: A Rosetta Stone approach","volume":"8","author":"Koob","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bpsgos.2024.100368_bib20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.alcohol.2009.09.024","article-title":"Stress, alcohol craving, and relapse risk: Mechanisms and viable treatment targets","volume":"43","author":"Mason","year":"2009","journal-title":"Alcohol"},{"key":"10.1016\/j.bpsgos.2024.100368_bib21","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1172\/JCI79828","article-title":"Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals","volume":"125","author":"Vendruscolo","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpsgos.2024.100368_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2017.04.032","article-title":"Emerging pharmacotherapies for alcohol use disorder","volume":"122","author":"Mason","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bpsgos.2024.100368_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159103","article-title":"Preclinical and clinical evidence for suppression of alcohol intake by apremilast","volume":"133","author":"Grigsby","year":"2023","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpsgos.2024.100368_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2023.100604","article-title":"A\u00a0reverse translational study of PPAR-\u03b1 agonist efficacy in human and rodent models relevant to alcohol use disorder","volume":"29","author":"Mason","year":"2024","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.bpsgos.2024.100368_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1037\/0022-006X.68.4.573","article-title":"Stepped care as a heuristic approach to the treatment of alcohol problems","volume":"68","author":"Sobell","year":"2000","journal-title":"J\u00a0Consult Clin Psychol"},{"key":"10.1016\/j.bpsgos.2024.100368_bib26","series-title":"International Affective Picture System (IAPS): Affective Ratings of Pictures and Instruction Manual. Technical Report A-8","author":"Lang","year":"2008"},{"key":"10.1016\/j.bpsgos.2024.100368_bib27","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/clinchem\/hvaa094","article-title":"Understanding patient-based real-time quality control using simulation modeling","volume":"66","author":"Bietenbeck","year":"2020","journal-title":"Clin Chem"},{"key":"10.1016\/j.bpsgos.2024.100368_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1037\/1082-989X.8.3.254","article-title":"Modern robust data analysis methods: Measures of central tendency","volume":"8","author":"Wilcox","year":"2003","journal-title":"Psychol Methods"},{"key":"10.1016\/j.bpsgos.2024.100368_bib29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2017.01.007","article-title":"The peroxisome proliferator-activated receptor alpha agonist fenofibrate attenuates alcohol self-administration in rats","volume":"116","author":"Haile","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bpsgos.2024.100368_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.12688\/f1000research.138477.1","article-title":"A\u00a0randomized interventional clinical trial assessing the safety and effectiveness of PeaNoc XL tablets in managing joint pain and inflammation in arthritis patients","volume":"12","author":"Kadanangode Narayanaswam","year":"2023","journal-title":"F1000Res"},{"key":"10.1016\/j.bpsgos.2024.100368_bib31","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3390\/nu15061350","article-title":"Palmitoylethanolamide in the treatment of chronic pain: A systematic review and meta-analysis of double-blind randomized controlled trials","volume":"15","author":"Lang-Illievich","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bpsgos.2024.100368_bib32","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/bcp.13020","article-title":"Palmitoylethanolamide for the treatment of pain: Pharmacokinetics, safety and efficacy","volume":"82","author":"Gabrielsson","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bpsgos.2024.100368_bib33","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1007\/s00213-017-4691-9","article-title":"Blockade of alcohol escalation and \u201crelapse\u201d drinking by pharmacological FAAH inhibition in male and female C57BL\/6J mice","volume":"234","author":"Zhou","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bpsgos.2024.100368_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-cellbio-101011-155833","article-title":"TRP channels and pain","volume":"29","author":"Julius","year":"2013","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.bpsgos.2024.100368_bib35","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/j.pain.0000000000002215","article-title":"Sex differences in neuroimmune and glial mechanisms of pain","volume":"162","author":"Gregus","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.bpsgos.2024.100368_bib36","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1172\/JCI128022","article-title":"Schwann cells expressing nociceptive channel TRPA1 orchestrate ethanol-evoked neuropathic pain in mice","volume":"129","author":"De Logu","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bpsgos.2024.100368_bib37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.neuropharm.2009.01.007","article-title":"Deletion of vanilloid receptor (TRPV1) in mice alters behavioral effects of ethanol","volume":"56","author":"Blednov","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bpsgos.2024.100368_bib38","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/bph.14044","article-title":"Targeting nociceptive transient receptor potential channels to treat chronic pain: Current state of the field","volume":"175","author":"Moran","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bpsgos.2024.100368_bib39","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/ATVBAHA.123.319434","article-title":"Novel strategy to combat the procoagulant phenotype in heparin-induced thrombocytopenia using 12-LOX inhibition","volume":"43","author":"Renna","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bpsgos.2024.100368_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042399","article-title":"Endocannabinoids measurement in human saliva as potential biomarker of obesity","volume":"7","author":"Matias","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bpsgos.2024.100368_bib41","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1194\/jlr.M071738","article-title":"Sweat lipid mediator profiling: A noninvasive approach for cutaneous research","volume":"58","author":"Agrawal","year":"2017","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.bpsgos.2024.100368_bib42","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3390\/cancers12040870","article-title":"Urine endocannabinoids as novel non-invasive biomarkers for bladder cancer at early stage","volume":"12","author":"Vago","year":"2020","journal-title":"Cancers (Basel)"}],"container-title":["Biological Psychiatry Global Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667174324000818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667174324000818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T11:26:29Z","timestamp":1731756389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667174324000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2667174324000818"],"URL":"https:\/\/doi.org\/10.1016\/j.bpsgos.2024.100368","relation":{},"ISSN":["2667-1743"],"issn-type":[{"value":"2667-1743","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Predictive Value of Plasma Bioactive Lipids on Craving in Human Volunteers With Alcohol Use Disorder","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry Global Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpsgos.2024.100368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 THE AUTHORS. Published by Elsevier Inc on behalf of the Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}],"article-number":"100368"}}